China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

download China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

of 8

Transcript of China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    1/8

    Major Distribution Area

    Second Distribution Area

    Lesser Distribution Area

    Liaoning

    Jilin

    Heilongjiang

    Inner Mongolia

    Xinjiang

    Tibet

    Qinghai

    Hebei

    Shanxi

    Jiangsu

    Zhejiang

    Anhui

    Fujian

    Jiangxi

    Shandong

    Henan

    Hubei

    Hunan

    GuangdongGuangxi

    Hainan

    Sichuan

    Guizhou

    Yunnan

    Shaanxi

    Gansu

    Ningxia

    Chongqing

    Beijing

    Tianjin

    Shanghai

    China Pharmaceutical & Medicine Mfg. Industry Profile

    China Industry Code: 2720

    According to the industry distribution index released by Zeefer, the major distribution areas of pharmaceutical &

    medicine mfg. industry across China include: Jiangsu, Guangdong, Shandong, and the second distribution areas

    include: Beijing, Shanghai, Zhejiang, Heilongjiang, Tianjin, Liaoning and Hebei.

    Beijing Zeefer Consulting Ltd.

    Jun. 2011

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    2/8

    This report is based on Chinese industry classification (Industrial Classification For National Economic Activities, GB/T 4754-2002).

    What will you get from this report?

    Present you with a list of top 20 enterprises inside the industry;

    Regions Covered By This Report

    All the 31 provincial regions in Mainland China;

    Top 20 cities in terms of pharmaceutical & medicine mfg. industry.

    Enterprise Types Covered By This Report

    Top 20 enterprises;

    Enterprises Funded by Foreign Countries (territories), Hong Kong, Macau and Taiwan;

    Chinese State-owned Enterprises;

    Collective-owned Enterprises;

    Cooperative Enterprises;

    Joint-Equity Enterprises;

    Introduction

    Through a comparative analysis on the development of pharmaceutical & medicine mfg. industry in 31 provincial regions and 20 major cities in visualized

    form of data map, the report provides key data and concise analyses on the pharmaceutical & medicine mfg. industry in China, a list of top 20 enterprisesin the sector as well as the comparison on investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign

    enterprises in pharmaceutical & medicine mfg. industry across China based on a comprehensive comparison of operating conditions among different

    enterprise types.

    Additionally, by original creation of ZEEFER Industry Distribution Index, the report directly shows the difference in various regions of Mainland China interms of pharmaceutical & medicine mfg. industry, providing an important reference for investors' selection of target regions to make investment.

    To get a comprehensive picture on distribution of and difference in performance in regions of Mainland China in terms of the pharmaceutical & medicine

    mfg. industry;

    To figure out the hot regions in China for pharmaceutical & medicine mfg. industry, find out the potential provinces and cities suitable for investment as

    well as the economic development level and investment environment in these regions; To get a clear picture on the overall development, industry size and growth trend of pharmaceutical & medicine mfg. industry across China in the past 3years;

    To get a clear picture on development status of foreign enterprises, state-owned enterprises, and private enterprises in recent years as well as the

    industry position of the above ownerships;

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    3/8

    Private Enterprises.

    ZEEFER Industry Distribution Index

    Key Statistic Indicators Covered By This Report

    Industrial Sales Value

    Number Of Employees

    Enterprise Number

    Sales Revenue

    Profits

    Rate Of Return On Sales

    Rate Of Return On Assets Rate Of Return On Net Assets

    Number Of Enterprises In Red

    Range Of Loss

    Total Losses

    Percentage Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises In Terms Of The Sales Revenue

    GDP Growth Rate Of GDP

    GDP Per Capita

    Growth Rate Of GDP Per Capita

    Growth Rate Of The Added Value Of Primary Industry

    Growth Rate Of The Added Value Of Secondary Industry

    Growth Rate Of The Added Value Of The Tertiary Industry

    Industrial Value-Added Of Enterprises Above Designated Size

    Growth Rate Of Industrial Value-Added Of Enterprises Above Designated Size ......

    Percentage Of Foreign-Funded Enterprises In All Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises In Terms Of The SalesRevenue

    It is an indicator through aggregate weighted computation based on the three authority statistics of enterprise numbers, sales revenue and profit by region

    and corporate ownership, and in accordance with the regional distribution of leading enterprises inside the sector. Through horizontal comparison on the

    pharmaceutical & medicine mfg. industry development in different provinces, municipalities, and autonomous regions, the ZEEFER Industry DistributionIndex is specially designed to truly reflect the conditions of regional distribution for the pharmaceutical & medicine mfg. industry, providing a quantitative,

    visual and reliable reference for relevant users to make decisions. The ZEEFER Industry Distribution Index adopts a hundred mark system. For a certainregion, the higher the score, the higher the distribution concentration in this region and the industry position of the region shall be more important.

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    4/8

    Beijing Zeefer Consulting Ltd. and (or) its affiliates (hereafter, "Zeefer") provides this report with the greatest possible

    care. Nevertheless, Zeefer makes no guarantee whatsoever regarding the accuracy, utility, or certainty of the

    information in this report. Further, Zeefer disclaims any and all responsibility for damages that may result from the use

    or non-use of the information in this report.

    The information in this report may be incomplete and/or may differ in expression from other information in elsewhere by

    other means. The information contained in this report may also be changed or removed without prior notice.

    Declaration

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    5/8

    1. Overview

    2.

    3. Introduction To Major Cities

    4.

    5. Nationwide Distribution Of Foreign-Funded Enterprises6. Nationwide Distribution By Enterprise Numbers

    7. Sales Revenue Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Region

    8.

    9. Nationwide Distribution Of Top 100 Enterprises In Terms Of Sales Revenue

    10. Comparison Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises

    10.1 Operating Status Of Top 10 Areas With Highest Total Profits

    10.2 Comparison On Operating Status Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Region

    11. Analysis On Operating Status Of Enterprises By Corporate Ownership

    12. Analysis On The Changes In Number Of Enterprises By Corporate Ownership

    13. Analysis On The Changes In Sales Revenue By Corporate Ownership

    14. Comparison On The Rate Of Return On Assets Of Enterprises

    14.1 Comparison On The Rate Of Return On Assets By Corporate Ownership

    14.2 Comparison On The Rate Of Return On Assets By Corporate Size

    14.3

    15. Comparison On The Investment Environment Indexes Of 10 Major Regions

    16. List Of Top 20 Enterprises In Terms Of Sales Revenue

    17. Index Explanation

    Comparison On The Rate Of Return On Assets Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Major

    Distribution Areas

    Table of Contents

    The Nationwide Distribution Of Pharmaceutical & Medicine Mfg. Industry In China

    Nationwide Distribution Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises In Pharmaceutical & Medicine

    Mfg. Industry

    Sales Revenue In Different Regions For Pharmaceutical & Medicine Mfg. Industry

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    6/8

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    7/8

    Sample Report Beijing Zeefer Consulting Ltd.

    2010 2009 2008 2010 2009 2008 # # # # # #

    10.6 10.1 9.3 19.6 19.4 18.5 # # # # # #

    All 13.8 13.3 12.2 24.2 23.5 22.4 # # # # # #

    Jiangsu 16.5 15.0 16.1 25.7 23.2 24.9 # # # # # #

    Guangdong 10.4 10.6 8.0 16.1 16.8 14.2 # # # # # #

    Shandong 18.1 13.6 14.4 44.2 34.7 34.9 # # # # # #

    # # # # # #

    # # # # # #

    14.3 Comparison On The Rate Of Return On Assets Of Foreign-Funded Enterprises And HK, Macau And Taiwan-Funded Enterprises By Major Distribution

    Areas (2008-2010)

    In 2010, the rate of return on assets for foreign-funded enterprises and HK, Macau and Taiwan-funded enterprises was 13.8%, 3.2% higher than

    nationwide average. Among foreign-funded enterprises and HK, Macau and Taiwan-funded enterprises in following major distribution areas, thoseenterprises in Shandong realized the highest rate of return on assets, and those in Guangdong achieved the lowest ROAs. Those foreign-funded

    and HK, Macau and Taiwan-funded enterprises in Shandong realized a ROA of 18.1% in 2010, 7.5% higher than the nationwide average, 4.3%higher than that of nationwide average of all foreign-funded and HK, Macau and Taiwan-funded enterprises.

    Rate Of Return On Net Assets %

    Foreign-Funded

    And HK, MacauAnd Taiwan-

    Funded

    Enterprises

    National Average

    Rate Of Return On Assets %

    Rate Of Return On Assets ForForeign-Funded And HK,

    Macau And Taiwan-Funded Enterprises By Major

    Distribution Areas (2008-2010)

    0.00

    2.00

    4.00

    6.00

    8.00

    10.00

    12.0014.00

    16.00

    18.00

    20.00

    2008 2009 2010

    All

    Jiangsu

    Guangdong

    Shandong

    Rate Of Return On Net Assets For Foreign-Funded And

    HK, Macau And Taiwan-Funded Enterprises By Major

    Distribution Areas (2008-2010)

    0.00

    5.00

    10.00

    15.00

    20.00

    25.00

    30.0035.00

    40.00

    45.00

    50.00

    2008 2009 2010

    All

    Jiangsu

    Guangdong

    Shandong

    Tel: +86 10 68324716 Fax: +86 10 87750776

    Company Site: www.Zeefer.org Online Reports Store: www.AllChinaReports.com 18

  • 8/2/2019 China Pharmaceutical Medicine Mfg. Industry Profile Cic2720

    8/8

    Beijing Zeefer Consulting Ltd.

    Cardholder's Signature:

    Please fax this order form to: +86 10 87750776

    If you have any question please contact us at: Email: [email protected] Telephone: +86 10 68324716

    Job Title:

    Tel:

    Organization:

    Fax:

    Payment Details:Pay by credit card Visa Master Card American Express JCB

    Contact Details:

    MrMrsMs Family Name:Given Name:

    Order Form

    Report Name: China Pharmaceutical & Medicine Mfg. Industry Profile

    Report Type: Industry Report

    Price, Format and Licence:

    US$580 for Single User in PDFUS$870 for Five Users in PDFUS$1450 for Enterprise License in PDFIf you wish to order this report online, please visit the following link. It is simple, safe and faster:

    http://www.allchinareports.com/pharmaceuticals-medical-devices/pharmaceutical/china-pharmaceutical-medicine-

    mfg.-industry-profile-cic2720.html

    Cardholder's Name:

    Card Number:

    Expiry Date: CVV Number:

    Address:

    City: Zip Code: Country:

    Email Address:

    Tel: +86 10 68324716 Fax: +86 10 87750776

    Company Site: www.Zeefer.org Online Reports Store: www.AllChinaReports.com